BHK Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $904K | Sell |
2,496
-20
| -0.8% | -$6.85K | 0.27% | 42 |
|
|
2026
Q1 | $885K | Sell |
2,516
-219
| -8% | -$78.1K | 0.3% | 38 |
|
|
2025
Q4 | $895K | Buy |
2,735
+75
| +3% | +$23.8K | 0.29% | 37 |
|
|
2025
Q3 | $751K | Sell |
2,660
-74
| -3% | -$21.5K | 0.28% | 32 |
|
|
2025
Q2 | $763K | Buy |
2,734
+75
| +3% | +$21.2K | 0.3% | 32 |
|
|
2025
Q1 | $828K | Buy |
2,659
+200
| +8% | +$59.1K | 0.35% | 29 |
|
|
2024
Q4 | $641K | Buy |
2,459
+211
| +9% | +$62.6K | 0.24% | 35 |
|
|
2024
Q3 | $724K | Sell |
2,248
-235
| -9% | -$76.9K | 0.27% | 32 |
|
|
2024
Q2 | $776K | Sell |
2,483
-54
| -2% | -$15.9K | 0.3% | 32 |
|
|
2024
Q1 | $721K | Buy |
2,537
+985
| +63% | +$288K | 0.28% | 32 |
|
|
2023
Q4 | $447K | Sell |
1,552
-240
| -13% | -$65.4K | 0.26% | 29 |
|
|
2023
Q3 | $482K | Sell |
1,792
-229
| -11% | -$57.1K | 0.22% | 38 |
|
|
2023
Q2 | $449K | Buy |
2,021
+130
| +7% | +$30.2K | 0.19% | 45 |
|
|
2023
Q1 | $457K | Buy |
1,891
+406
| +27% | +$99.7K | 0.2% | 43 |
|
|
2022
Q4 | $390K | Sell |
1,485
-405
| -21% | -$109K | 0.22% | 43 |
|
|
2022
Q3 | $426K | Sell |
1,890
-20
| -1% | -$4.85K | 0.21% | 39 |
|
|
2022
Q2 | $465K | Buy |
1,910
+285
| +18% | +$69.8K | 0.21% | 40 |
|
|
2022
Q1 | $393K | Buy |
1,625
+1
| +0.1% | +$230 | 0.16% | 46 |
|
|
2021
Q4 | $365K | Buy |
1,624
+65
| +4% | +$13.7K | 0.14% | 52 |
|
|
2021
Q3 | $332K | Sell |
1,559
-15
| -1% | -$3.45K | 0.14% | 55 |
|
|
2021
Q2 | $384K | Sell |
1,574
-24
| -2% | -$5.9K | 0.16% | 47 |
|
|
2021
Q1 | $367K | Hold |
1,598
| – | – | 0.17% | 45 |
|
|
2020
Q4 | $367K | Buy |
1,598
+115
| +8% | +$26.5K | 0.17% | 43 |
|
|
2020
Q3 | $377K | Buy |
1,483
+150
| +11% | +$37.2K | 0.21% | 35 |
|
|
2020
Q2 | $314K | Sell |
1,333
-49
| -4% | -$11.2K | 0.19% | 38 |
|
|
2020
Q1 | $280K | Buy |
1,382
+105
| +8% | +$22.9K | 0.2% | 39 |
|
|
2019
Q4 | $308K | Sell |
1,277
-400
| -24% | -$88.2K | 0.18% | 44 |
|
|
2019
Q3 | $325K | Sell |
1,677
-520
| -24% | -$99.8K | 0.19% | 60 |
|
|
2019
Q2 | $405K | Buy |
2,197
+82
| +4% | +$14.7K | 0.23% | 59 |
|
|
2019
Q1 | $402K | Buy |
2,115
+1
| +0% | +$191 | 0.24% | 57 |
|
|
2018
Q4 | $412K | Hold |
2,114
| – | – | 0.31% | 41 |
|
|
2018
Q3 | $438K | Buy |
2,114
+286
| +16% | +$56.4K | 0.29% | 43 |
|
|
2018
Q2 | $337K | Buy |
+1,828
| New | +$323K | 0.23% | 48 |
|
Other funds holding AMGN
BHK Investment Advisors's AMGN Position: Q2 2026 in Review
BHK Investment Advisors reduced its Amgen (AMGN) stake by 0.79% in Q2 2026, selling an estimated $6.85K and leaving 2,496 shares worth $904K. The position accounts for 0.27% of the portfolio, ranked #42.
BHK Investment Advisors first reported a position in AMGN in Q2 2018 and has held it in 33 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- BHK Investment Advisors held 2,496 shares of Amgen worth $904K as of Q2 2026.
- BHK Investment Advisors sold 20 Amgen shares in Q2 2026, an estimated $6.85K.
- Amgen made up 0.27% of BHK Investment Advisors's portfolio in Q2 2026, its #42 holding.
- BHK Investment Advisors first reported a position in Amgen in Q2 2018 and has held it in 33 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on BHK Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.